SIGA - SIGA Technologies, Inc.
SIGA Technologies, Inc. , a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus.
As of May 15, 2026: spot at $4.24, ATM IV 22.2%, net GEX $3.4K.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Market Cap
- $309.1M
- P/E Ratio
- 15.24
- Beta
- 0.85
- 52-Week Range
- 4.29-9.62
- Dividend Yield
- $0.60
- CEO
- Diem Nguyen
- Employees
- 46
- IPO Date
- Sep 10, 1997
- Exchange
- NASDAQ
What SIGA Looks Like to Options Traders Today
IV rank of 0.0% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); positive net gamma exposure ($3.4K) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (0.225) prices calls richer than puts, often reflecting upside speculation or squeeze risk.
What This Page Covers
The SIGA overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked SIGA overview questions
- What is SIGA?
- SIGA is the ticker symbol for SIGA Technologies, Inc., a listed security. SIGA Technologies, Inc. , a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Listed on NASDAQ. SIGA is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the SIGA options snapshot look like today?
- As of May 15, 2026, the SIGA options snapshot shows spot at $4.24, ATM IV 22.2%, IV rank 0.0%, net GEX $3.4K, expected move 6.36%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are SIGA's key statistics?
- SIGA Technologies, Inc. (SIGA) carries a market capitalization of $309.1M, trailing P/E ratio of 15.24, beta of 0.85 relative to the broader market, 52-week range of 4.29-9.62. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does SIGA belong to?
- SIGA Technologies, Inc. operates in the Healthcare sector, in the Drug Manufacturers - Specialty & Generic industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare SIGA's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the SIGA data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).